385 related articles for article (PubMed ID: 16900750)
1. Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions.
Merkler D; Schmelting B; Czéh B; Fuchs E; Stadelmann C; Brück W
Mult Scler; 2006 Aug; 12(4):369-74. PubMed ID: 16900750
[TBL] [Abstract][Full Text] [Related]
2. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
Genain CP; Nguyen MH; Letvin NL; Pearl R; Davis RL; Adelman M; Lees MB; Linington C; Hauser SL
J Clin Invest; 1995 Dec; 96(6):2966-74. PubMed ID: 8675668
[TBL] [Abstract][Full Text] [Related]
3. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.
Iglesias A; Bauer J; Litzenburger T; Schubart A; Linington C
Glia; 2001 Nov; 36(2):220-34. PubMed ID: 11596130
[TBL] [Abstract][Full Text] [Related]
4. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
Genain CP; Cannella B; Hauser SL; Raine CS
Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
[TBL] [Abstract][Full Text] [Related]
5. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.
Stefferl A; Brehm U; Linington C
J Neural Transm Suppl; 2000; (58):123-33. PubMed ID: 11128602
[TBL] [Abstract][Full Text] [Related]
6. Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells.
Kap YS; Smith P; Jagessar SA; Remarque E; Blezer E; Strijkers GJ; Laman JD; Hintzen RQ; Bauer J; Brok HP; 't Hart BA
J Immunol; 2008 Feb; 180(3):1326-37. PubMed ID: 18209026
[TBL] [Abstract][Full Text] [Related]
7. Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey.
Merkler D; Böscke R; Schmelting B; Czéh B; Fuchs E; Brück W; Stadelmann C
Brain Pathol; 2006 Apr; 16(2):117-23. PubMed ID: 16768751
[TBL] [Abstract][Full Text] [Related]
8. Experimental Autoimmune Encephalomyelitis (EAE) Model of Cynomolgus Macaques Induced by Recombinant Human MOG1-125 (rhMOG1-125) Protein and MOG34-56 Peptide.
Peng Z; Zhang L; Wang H; He X; Peng X; Zhang Q; Liu H; Rao J; Wang H; Wu J; Sun Y
Protein Pept Lett; 2018 Feb; 24(12):1166-1178. PubMed ID: 29141529
[TBL] [Abstract][Full Text] [Related]
9. Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant.
Jagessar SA; Heijmans N; Blezer EL; Bauer J; Weissert R; 't Hart BA
J Neuroinflammation; 2015 Sep; 12():169. PubMed ID: 26377397
[TBL] [Abstract][Full Text] [Related]
10. Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus.
Genain CP; Hauser SL
Immunol Rev; 2001 Oct; 183():159-72. PubMed ID: 11782255
[TBL] [Abstract][Full Text] [Related]
11. Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model.
Kap YS; van Driel N; Arends R; Rouwendal G; Verolin M; Blezer E; Lycke N; 't Hart BA
Clin Exp Immunol; 2015 Apr; 180(1):28-39. PubMed ID: 25393803
[TBL] [Abstract][Full Text] [Related]
12. Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire.
Mathey E; Breithaupt C; Schubart AS; Linington C
Eur J Immunol; 2004 Aug; 34(8):2065-71. PubMed ID: 15259003
[TBL] [Abstract][Full Text] [Related]
13. Rhesus monkeys are highly susceptible to experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein: characterisation of immunodominant T- and B-cell epitopes.
Kerlero de Rosbo N; Brok HP; Bauer J; Kaye JF; 't Hart BA; Ben-Nun A
J Neuroimmunol; 2000 Oct; 110(1-2):83-96. PubMed ID: 11024537
[TBL] [Abstract][Full Text] [Related]
14. Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule.
Brok HP; Uccelli A; Kerlero De Rosbo N; Bontrop RE; Roccatagliata L; de Groot NG; Capello E; Laman JD; Nicolay K; Mancardi GL; Ben-Nun A; Hart BA
J Immunol; 2000 Jul; 165(2):1093-101. PubMed ID: 10878388
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive measurement of brain damage in a primate model of multiple sclerosis.
't Hart BA; Vogels J; Bauer J; Brok HP; Blezer E
Trends Mol Med; 2004 Feb; 10(2):85-91. PubMed ID: 15102362
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
[TBL] [Abstract][Full Text] [Related]
17. Late complications of immune deviation therapy in a nonhuman primate.
Genain CP; Abel K; Belmar N; Villinger F; Rosenberg DP; Linington C; Raine CS; Hauser SL
Science; 1996 Dec; 274(5295):2054-7. PubMed ID: 8953031
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
Pacini G; Ieronymaki M; Nuti F; Sabatino G; Larregola M; Aharoni R; Papini AM; Rovero P
J Pept Sci; 2016 Jan; 22(1):52-8. PubMed ID: 26663200
[TBL] [Abstract][Full Text] [Related]
19. EAE in the common marmoset Callithrix jacchus.
Uccelli A; Giunti D; Capello E; Roccatagliata L; Mancardi GL
Int MS J; 2003 Apr; 10(1):6-12. PubMed ID: 12906764
[TBL] [Abstract][Full Text] [Related]
20. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Lee DH; Linker RA
Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
